The brain may be about to have its Ozempic moment
Summary
The article discusses a potential breakthrough in neuroscience that could lead to transformative brain treatments, drawing parallels to the significant impact of Ozempic on weight loss.
Similar Articles
GLP-1 drugs led to weight loss and reversed depression-like behavior in mice
A study from Southeast University found that GLP-1 drugs like Ozempic reverse depression-like behavior in mice by promoting growth of Lactobacillus delbrueckii, which produces endocannabinoids that reduce stress effects.
The race to engineer new knobs for the human brain
The article reports on the advancement of chemogenetics (DREADDs) into human clinical trials in China for treating neurological disorders, highlighting new therapeutic possibilities for brain control.
Most powerful obesity drug yet: People lost up to 25% of weight in trial
A next-generation obesity drug, Retatrutide, shows up to 25% weight loss in clinical trials, building on GLP-1 based treatments by combining GLP-1, GIP, and glucagon hormones.
Hair Loss Was Just the Start. Ozempic Users Are Also Reporting Nail Trouble
European researchers found that GLP-1 users are significantly more likely to develop hair loss and nail problems, particularly nail detachment, compared to non-users, adding to known risks of semaglutide and tirzepatide.
Popular weight loss drugs linked to a surprising fingernail problem
A multinational controlled study presented at the EADV Congress 2026 found that GLP-1 weight loss and diabetes drugs (Ozempic, Wegovy, Mounjaro, Zepbound) are associated with a significantly higher rate of nail detachment and discoloration, with weight loss alone not fully explaining the effect.